ST-Segment Elevation Myocardial Infarction–Ideal Scenario for Bioresorbable Vascular Scaffold Implantation?–

G Scalone, S Brugaletta, O Gómez-Monterrosas… - Circulation …, 2015 - jstage.jst.go.jp
Bioresorbable vascular scaffolds (BVS) represent a breakthrough technology for
percutaneous coronary intervention (PCI). In this context, because of the unique properties …

Bioresorbable vascular scaffold during ST-elevation myocardial infarction: a systematic review

F Picard, Q de Hemptinne, R Avram, HQ Ly… - Canadian Journal of …, 2017 - Elsevier
Background The bioresorbable vascular scaffold (BVS) represents a novel technology
designed to overcome the long-term limitations of metallic coronary stent implantation in …

One-Year Clinical and Computed Tomography Angiographic Outcomes After Bioresorbable Vascular Scaffold Implantation During Primary Percutaneous Coronary …

P Widimsky, R Petr, P Tousek, M Maly… - Circulation …, 2015 - Am Heart Assoc
Background—Bioresorbable vascular scaffolds (BVS) represent promising new technology,
but data on their long-term outcomes in ST-segment–elevation myocardial infarction …

Clinical findings after bioresorbable vascular scaffold implantation in an unrestricted cohort of patients with ST-segment elevation myocardial infarction (from the RAI …

E Moscarella, A Ielasi, A Varricchio… - International journal of …, 2018 - Elsevier
Background The bioresorbable vascular scaffold (BVS) technology may be an appealing
option in ST-segment elevation myocardial infarction (STEMI) patients. However, the …

Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study 'Prague 19'

V Kočka, M Malý, P Toušek, T Buděšínský… - European heart …, 2014 - academic.oup.com
Abstract Aims Bioresorbable vascular scaffolds (BVSs) have been studied in chronic
coronary artery disease, but not in acute ST-segment elevation myocardial infarction …

[HTML][HTML] Bioresorbable vascular scaffolds in patients with acute myocardial infarction: a new step forward to optimized reperfusion?

F Alfonso, J Cuesta, T Bastante, F Rivero… - Journal of Thoracic …, 2016 - ncbi.nlm.nih.gov
Bioresorbable vascular scaffolds (BVS) represent a disruptive technology that has caused a
new revolution in interventional cardiology. BVS appear to be particularly appealing in …

[PDF][PDF] Long-term follow-up after bioresorbable vascular scaffold implantation in STEMI patients: PRAGUE-19 study update

P Toušek, V Kočka, M Malý, M Kozel, R Petr… - …, 2016 - researchgate.net
Aims: Early clinical results after implantation of bioresorbable vascular scaffolds (BVS) in ST-
elevation myocardial infarction (STEMI) are encouraging, but long-term data are missing …

[HTML][HTML] Everolimus-eluting bioresorbable vascular scaffold (BVS) implantation in patients with ST-segment elevation myocardial infarction (STEMI)

T Kajiya, M Liang, RK Sharma… - …, 2013 - eurointervention.pcronline.com
Aims: Recent studies have demonstrated favourable clinical outcomes for the everolimus-
eluting bioresorbable vascular scaffold (BVS) ABSORB™ in patients with stable coronary …

ST elevation myocardial infarction treated with bioresorbable vascular scaffold: rationale and first cases

V Kočka, L Lisa, P Toušek, T Buděšínský… - European heart …, 2013 - academic.oup.com
Bioresorbable vascular scaffolds (BVS) have the potential to start new era in interventional
cardiology. First clinical studies in stable coronary artery disease have demonstrated a good …

Feasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenarios

M Jaguszewski, JR Ghadri, M Zipponi… - Clinical Research in …, 2015 - Springer
Background Bioresorbable vascular scaffolds (BVS) have become an emerging tool to treat
coronary artery disease. However, the current use of BVS is still widely restricted to stable …